Clinical

Dataset Information

0

A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum


ABSTRACT: This expanded access study will assess the efficacy and safety of intravenous (IV) bevacizumab in combination with chemotherapy regimens as first-line treatment of metastatic cancer of the colon or rectum. The anticipated median time on study treatment is approximately 10 months, and the target sample size is 40 individuals.

DISEASE(S): Neoplasm Metastasis,Colorectal Cancer,Colonic Neoplasms

PROVIDER: 2200653 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2092632 | ecrin-mdr-crc
| 2093553 | ecrin-mdr-crc
2009-02-14 | GSE11910 | GEO
2012-08-20 | GSE38753 | GEO
2009-02-26 | E-GEOD-11910 | biostudies-arrayexpress
2012-08-20 | E-GEOD-38753 | biostudies-arrayexpress
| PRJNA625122 | ENA
| 2089695 | ecrin-mdr-crc
2008-06-16 | E-GEOD-9254 | biostudies-arrayexpress
2020-09-08 | GSE143782 | GEO